S'abonner

The association between maternal antioxidant levels in midpregnancy and preeclampsia - 31/10/15

Doi : 10.1016/j.ajog.2015.07.027 
Jacqueline M. Cohen, PhD a, e, , Michael S. Kramer, MD, MSc a, b, Robert W. Platt, PhD a, b, Olga Basso, PhD a, c, Rhobert W. Evans, PhD f, Susan R. Kahn, MD, MSc a, d, e
a Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada 
b Department of Pediatrics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada 
c Department of Obstetrics and Gynecology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada 
d Department of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada 
e Center for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada 
f Department of Epidemiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 

Corresponding author: Jacqueline M. Cohen, PhD.

Abstract

Objective

We sought to determine whether midpregnancy antioxidant levels are associated with preeclampsia, overall and by timing of onset.

Study Design

We carried out a case-control study, nested within a cohort of 5337 pregnant women in Montreal, Quebec, Canada. Blood samples obtained at 24–26 weeks were assayed for nonenzymatic antioxidant levels among cases of preeclampsia (n = 111) and unaffected controls (n = 441). We excluded women diagnosed with gestational hypertension only. We used logistic regression with the z-score of each antioxidant level as the main predictor variable for preeclampsia risk. We further stratified early-onset (<34 weeks) and late-onset preeclampsia and carried out multinomial logistic regression. Finally, we assessed associations between antioxidant biomarkers and timing of onset (in weeks) by Cox regression, with appropriate selection weights. We summed levels of correlated biomarkers (r2 > 0.3) and log-transformed positively skewed distributions. We adjusted for body mass index, nulliparity, preexisting diabetes, hypertension, smoking, and proxies for ethnicity and socioeconomic status.

Results

The odds ratios for α-tocopherol, α-tocopherol:cholesterol, lycopene, lutein, and carotenoids (sum of α-carotene, β-carotene, anhydrolutein, α-cryptoxanthin, and β-cryptoxanthin) suggested an inverse association between antioxidant levels and overall preeclampsia risk; however, only lutein was significantly associated with overall preeclampsia in adjusted models (odds ratio, 0.60; 95% confidence interval, 0.46–0.77) per SD. In multinomial logistic models, the relative risk ratio (RRR) estimates for the early-onset subgroup were farther from the null than those for the late-onset subgroup. The ratio of α-tocopherol to cholesterol and retinol were significantly associated with early- but not late-onset preeclampsia: RRRs (95% confidence intervals) for early-onset preeclampsia 0.67 (0.46–0.99) and 1.61 (1.12–2.33), respectively. Lutein was significantly associated with both early- and late-onset subtypes in adjusted models; RRRs 0.53 (0.35–0.80) and 0.62 (0.47–0.82), respectively. Survival analyses confirmed these trends.

Conclusion

Most antioxidants were more strongly associated with early-onset preeclampsia, suggesting that oxidative stress may play a greater role in the pathophysiology of early-onset preeclampsia. Alternatively, reverse causality may explain this pattern. Lutein was associated with both early- and late-onset preeclampsia and may be a promising nutrient to consider in preeclampsia prevention trials, if this finding is corroborated.

Le texte complet de cet article est disponible en PDF.

Key words : antioxidants, carotenoids, preeclampsia, retinol, vitamin E


Plan


 This research was funded by the March of Dimes (Perinatal Epidemiological Research Initiative, PERI grant #20-FY04-3) and the Canadian Institutes of Health Research (CIHR) (MOP36424). J.M.C. received doctoral awards from Le Fonds de recherche du Québec–Santé (FRQS) (through a National Research Scientist award to S.R.K.) and the McGill Faculty of Medicine. R.W.P. and S.R.K. were supported by National Research Scientist awards from FRQS. J.M.C. received travel support from the Institute for Human Development, Child and Youth Health of CIHR, to present portions of this work. The sponsors had no role in conducting the study or decision to submit the work for publication.
 The authors report no conflict of interest.
 Cite this article as: Cohen JM, Kramer MS, Platt RW, et al. The association between maternal antioxidant levels in midpregnancy and preeclampsia. Am J Obstet Gynecol 2015;213:695.e1-13.


© 2015  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 213 - N° 5

P. 695.e1-695.e13 - novembre 2015 Retour au numéro
Article précédent Article précédent
  • Magnetic resonance imaging of acute appendicitis in pregnancy: a 5-year multiinstitutional study
  • Lauren M.B. Burke, Mustafa R. Bashir, Frank H. Miller, Evan S. Siegelman, Michele Brown, Mamdoh Alobaidy, Tracy A. Jaffe, Shahid M. Hussain, Suzanne L. Palmer, Bonnie L. Garon, Aytekin Oto, Caroline Reinhold, Susan M. Ascher, Danielle K. Demulder, Stephen Thomas, Shaun Best, James Borer, Ken Zhao, Fanny Pinel-Giroux, Isabela De Oliveira, Daniel Resende, Richard C. Semelka
| Article suivant Article suivant
  • Depletion of polymorphonuclear leukocytes has no effect on preterm delivery in a mouse model of Escherichia coli-induced labor
  • Yana Filipovich, Varkha Agrawal, Susan E. Crawford, Philip Fitchev, Xiaowu Qu, Jeremy Klein, Emmet Hirsch

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.